Schonfeld Strategic Advisors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,706
| Closed | -$249K | – | 3285 |
|
|
2022
Q2 | $249K | Buy |
+1,706
| New | +$249K | ﹤0.01% | 1697 |
|
|
2021
Q4 | – | Sell |
-4,700
| Closed | -$653K | – | 2750 |
|
|
2021
Q3 | $653K | Sell |
4,700
-1,300
| -22% | -$181K | 0.01% | 1069 |
|
|
2021
Q2 | $582K | Buy |
+6,000
| New | +$582K | 0.01% | 1081 |
|
|
2020
Q4 | – | Sell |
-13,525
| Closed | -$879K | – | 1985 |
|
|
2020
Q3 | $879K | Buy |
+13,525
| New | +$879K | 0.02% | 695 |
|
|
2020
Q1 | – | Sell |
-11,361
| Closed | -$619K | – | 1698 |
|
|
2019
Q4 | $619K | Sell |
11,361
-85,139
| -88% | -$4.64M | 0.02% | 666 |
|
|
2019
Q3 | $4.03M | Buy |
96,500
+90,900
| +1,623% | +$3.79M | 0.12% | 192 |
|
|
2019
Q2 | $245K | Sell |
5,600
-5,000
| -47% | -$219K | 0.01% | 834 |
|
|
2019
Q1 | $546K | Sell |
10,600
-182,000
| -94% | -$9.37M | 0.02% | 666 |
|
|
2018
Q4 | $7.12M | Buy |
192,600
+96,300
| +100% | +$3.56M | 0.27% | 92 |
|
|
2018
Q3 | $3.62M | Buy |
+96,300
| New | +$3.62M | 0.16% | 182 |
|
|
2018
Q2 | – | Sell |
-117,919
| Closed | -$3.04M | – | 1092 |
|
|
2018
Q1 | $3.04M | Buy |
117,919
+96,525
| +451% | +$2.49M | 0.23% | 130 |
|
|
2017
Q4 | $577K | Buy |
+21,394
| New | +$577K | 0.05% | 429 |
|